Innocoll's Unattributed - VI Round

Innocoll raised a round of funding on July 26, 2012. Investors include NewSmith Asset Management.

Innocoll is a global commercial stage specialty pharmaceutical company with late stage development programs targeting areas of significant unmet medical need. The company develops and manufactures a r…

Articles about Innocoll's Unattributed - VI Round: